Search

Your search keyword '"Poupon, Marie-France"' showing total 350 results

Search Constraints

Start Over You searched for: Author "Poupon, Marie-France" Remove constraint Author: "Poupon, Marie-France"
350 results on '"Poupon, Marie-France"'

Search Results

51. Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

55. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice

56. Abstract C115: Response to trastuzumab of HER2-overexpressing breast cancer patient-derived xenografts depends on the host mouse strain.

57. Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.

58. Two-and Three-dimensional Cell Structures Govern Epidermal Growth Factor Survival Function in Human Bladder Carcinoma Cell Lines

59. Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis.

60. Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts

61. Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors

62. Evaluation of the response to cabazitaxel of a docetaxel-responsive hormone-refractory prostate tumor xenograft model (HID28).

63. Abstract LB-352: Reversal of resistance to endocrine therapy by mTOR pathway targeting in a panel of patient derived breast cancer xenografts

65. Molecular profiling of patient-derived breast cancer xenografts

67. Abstract B11: A panel of patient-derived xenografts for preclinical efficacy studies in various breast cancer molecular subtypes.

68. Abstract 1603: Primary breast cancer xenografts maintain the molecular profiles of corresponding patients’ tumors and recapitulate a part of stroma microenvironment

70. A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer

71. Abstract 3275: Molecular characterization of human breast cancer xenografts reveals a strong genomic and gene expression stability

72. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts

73. Abstract A27: Efficacy of estramustine + docetaxel in docetaxel‐resistant human prostate cancer xenograft: a preclinical model of docetaxel resistance reversion

74. Correction: ADP Ribosylation Factor Like 2 (Arl2) Regulates Breast Tumor Aggressivity in Immunodeficient Mice

75. Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenografts

77. Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma

78. p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors

85. A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

86. Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response

87. Heterogeneous Metastasis Efficiency of Isogenic Orthotopic Colon Cancer Xenografts Reveals Distinctive Gene Expression Profiles

88. Establishment of Human Colon Cancer Cell Lines from Fresh Tumors versus Xenografts: Comparison of Success Rate and Cell Line Features

89. Impact of STI571 (Imatinib) on the Pharmacokinetics and In Vivo Efficacy of Etoposide and/or Ifosfamide.

91. High efficacy of combined rituximab and gemcitabine on Epstein–Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice

92. Up-Regulation of the Error-Prone DNA Polymerase κ Promotes Pleiotropic Genetic Alterations and Tumorigenesis

96. Distinct Responses of Xenografted Gliomas to Different Alkylating Agents Are Related to Histology and Genetic Alterations

100. Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction

Catalog

Books, media, physical & digital resources